...
首页> 外文期刊>International journal of clinical pharmacology and therapeutics >Pharmacokinetic characteristics of cisapride in elderly patients.
【24h】

Pharmacokinetic characteristics of cisapride in elderly patients.

机译:西沙必利在老年患者中的药代动力学特征。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We demonstrated pharmacokinetic characteristics of cisapride in elderly patients (85+/-6 years) who had suffered from constipation based on intestinal motility dysfunction. After a single p.o. dose of 2.5 mg cisapride tablet on the first day, plasma unchanged cisapride concentrations were detected at 9 points within 24 hours, using high-performance liquid chromatography method. Subsequently, the patients were treated with cisapride 3 times daily during next 26 days (from the day 2 to the day 27). On the 28th day, a cisapride tablet was given once in the morning and blood samples were obtained with the same procedure as that on day 1. The obtained elimination half-life averaged 21.8+/-10.6 hours, which seems to be considerably longer than those previously reported. The area under the time-concentration curve (AUC) on the day 28 was 2.7 times larger than AUC on the day 1, suggesting that plasma cisapride concentrations can become higher than expected by physicians when given 3 times daily to extremely elderly patients. Because cisapride sometimes induces fatal ventricular arrhythmias and sudden death in a concentration-dependent manner, this medicine should be administered once or twice per day to such patients.
机译:我们证明了西沙必利在因肠动力功能障碍而患有便秘的老年患者(85 +/- 6岁)中的药代动力学特征。一次过后在第一天服用2.5毫克西沙必利片后,使用高效液相色谱法在24小时内的9个点检测到血浆中未改变的西沙必利浓度。随后,在接下来的26天(从第2天到第27天)中,患者每天接受西沙必利3次治疗。在第28天,每天一次服用西沙必利片,并按照与第1天相同的步骤获得血样。获得的消除半衰期平均为21.8 +/- 10.6小时,这似乎比那些以前报道过的。第28天的时间浓度曲线(AUC)下的面积是第1天的AUC的2.7倍,这表明当每天3次给极度年老的患者服用时,血浆西沙必利的浓度可能会高于医生的预期。由于西沙必利有时会以浓度依赖的方式诱发致命性室性心律失常和猝死,因此应每天向此类患者给药一次或两次。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号